Histamine Human Immunoglobulin

· Hangzhou Grand Biologic Pharmaceutical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Histamine Human Immunoglobulin, covering 2024-02-09 to 2024-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU) [Phase 4]

See pricing